Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GYPE | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | P2RY1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | KRT81 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | CTNNB1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | ETNPPL | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | KIR3DL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | RP11-106M3.2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | PRKAR1B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | COL5A1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
mRNA | C11orf21 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |